Articles tagged as "HIV This Month 2017 #01 - January 2017"

Welcome to UNAIDS Science now and to the 1st issue of HIV this month in 2017! 

Antibody 10-1074 suppresses viremia in HIV-1-infected individuals published in Nature Medicine by Marina Caskey and colleagues this month reports that the antibody 10-1074 is effective at neutralizing HIV and is safe for humans. This brings science one step closer in finding an HIV cure.

We would like to take this opportunity to inform that we will be changing the format of HIV this month at the end of March.  For the past years, the digest that you have been receiving is a product of a systematic scan of HIV science literature each month followed by a process of prioritisation to choose papers relevant to UNAIDS and our readers. However, this systematic process is time-consuming and expensive.

There are a wide range of organisations providing selective commentaries on scientific publications.  We hope that our new format will still provide "added value" by relating papers to the UNAIDS strategy and goals.

We would be very pleased to receive any comments or suggestions as to what you, the readers, find most useful.

Watch this space!

Peter Godfrey-Faussett and Celeste Sandoval

UNAIDS

HIV This Month - January 2017

Welcome to HIV this month!  In this issue, we cover the following topics:

 

HIV testing and treatment


Combination prevention


Key populations


Elimination of gender inequalities


Financing


Health systems and services


To find out how you can access a majority of scientific journals free of charge, check the UNAIDS Science now website by clicking here. If you would like to subscribe to HIV this month issues, click here. Please let us know what your interests are and what you think of HIV this month by sending us an email here. If you would like to recommend an article for inclusion, please contact us. Remember, a wealth of information on the HIV epidemic and responses to it are accessible at www.unaids.org.

For full PDF access to this issue:
  • share
0 comments.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.